Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype.

Guiard BP, David DJ, Deltheil T, Chenu F, Le Maître E, Renoir T, Leroux-Nicollet I, Sokoloff P, Lanfumey L, Hamon M, Andrews AM, Hen R, Gardier AM.

Int J Neuropsychopharmacol. 2008 Feb;11(1):79-92.

PMID:
17559709
2.

Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.

Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM.

Neuropharmacology. 2008 Nov;55(6):1006-14. doi: 10.1016/j.neuropharm.2008.08.001. Review.

PMID:
18761360
3.

Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice.

Gardier AM, David DJ, Jego G, Przybylski C, Jacquot C, Durier S, Gruwez B, Douvier E, Beauverie P, Poisson N, Hen R, Bourin M.

J Neurochem. 2003 Jul;86(1):13-24.

4.
5.

Ethanol consumption and serotonin-1A (5-HT1A) receptor function in heterozygous BDNF (+/-) mice.

Hensler JG, Ladenheim EE, Lyons WE.

J Neurochem. 2003 Jun;85(5):1139-47.

6.

Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression.

Szapacs ME, Mathews TA, Tessarollo L, Ernest Lyons W, Mamounas LA, Andrews AM.

J Neurosci Methods. 2004 Dec 30;140(1-2):81-92.

PMID:
15589338
7.

Influence of brain-derived neurotrophic factor (BDNF) on serotonin neurotransmission in the hippocampus of adult rodents.

Benmansour S, Deltheil T, Piotrowski J, Nicolas L, Reperant C, Gardier AM, Frazer A, David DJ.

Eur J Pharmacol. 2008 Jun 10;587(1-3):90-8. doi: 10.1016/j.ejphar.2008.03.048.

PMID:
18474368
8.

Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice.

Renoir T, Païzanis E, El Yacoubi M, Saurini F, Hanoun N, Melfort M, Lesch KP, Hamon M, Lanfumey L.

Int J Neuropsychopharmacol. 2008 Dec;11(8):1149-62. doi: 10.1017/S1461145708009048.

PMID:
18611291
9.

Changes in 5-HT2A-mediated behavior and 5-HT2A- and 5-HT1A receptor binding and expression in conditional brain-derived neurotrophic factor knock-out mice.

Klein AB, Santini MA, Aznar S, Knudsen GM, Rios M.

Neuroscience. 2010 Sep 1;169(3):1007-16. doi: 10.1016/j.neuroscience.2010.05.054.

10.

Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.

van Amsterdam C, Seyfried CA.

Psychopharmacology (Berl). 2014 Jun;231(12):2547-58. doi: 10.1007/s00213-013-3428-7.

PMID:
24419272
11.

Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study.

Guiard BP, Mansari ME, Murphy DL, Blier P.

Int J Neuropsychopharmacol. 2012 Apr;15(3):349-61. doi: 10.1017/S1461145711000484.

PMID:
21439106
12.
13.
14.

Serotonin transporter in substance P (neurokinin 1) receptor knock-out mice.

David DJ, Froger N, Guiard B, Przybylski C, Jego G, Boni C, Hunt SP, De Felipe C, Hamon M, Jacquot C, Gardier AM, Lanfumey L.

Eur J Pharmacol. 2004 May 10;492(1):41-8.

PMID:
15145704
15.

Synergistic neurochemical and behavioural effects of acute intrahippocampal injection of brain-derived neurotrophic factor and antidepressants in adult mice.

Deltheil T, Tanaka K, Reperant C, Hen R, David DJ, Gardier AM.

Int J Neuropsychopharmacol. 2009 Aug;12(7):905-15. doi: 10.1017/S1461145709000017.

PMID:
19236729
16.

The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.

Arborelius L, Nomikos GG, Hertel P, Salmi P, Grillner P, Höök BB, Hacksell U, Svensson TH.

Naunyn Schmiedebergs Arch Pharmacol. 1996 May;353(6):630-40.

PMID:
8738296
17.

Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.

Mansari ME, Wiborg O, Mnie-Filali O, Benturquia N, Sánchez C, Haddjeri N.

Int J Neuropsychopharmacol. 2007 Feb;10(1):31-40.

PMID:
16448580
18.

In vivo efflux of serotonin in the dorsal raphe nucleus of 5-HT1A receptor knockout mice.

Bortolozzi A, Amargós-Bosch M, Toth M, Artigas F, Adell A.

J Neurochem. 2004 Mar;88(6):1373-9.

19.

Sex hormone-dependent desensitization of 5-HT1A autoreceptors in knockout mice deficient in the 5-HT transporter.

Bouali S, Evrard A, Chastanet M, Lesch KP, Hamon M, Adrien J.

Eur J Neurosci. 2003 Oct;18(8):2203-12.

PMID:
14622181
20.

Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study.

Gobbi G, Murphy DL, Lesch K, Blier P.

J Pharmacol Exp Ther. 2001 Mar;296(3):987-95.

Items per page

Supplemental Content

Support Center